SMTL ID : 7d85.1 (1 other biounit)

Crystal structure of anti-ErbB3 Fab ISU104 in complex with human ErbB3 extracellular domain 3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-1-1-1-mer

Ligands

4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)

NAG.1: 6 residues within 4Å: Chain A: H.80, M.81, H.82, N.83, P.187, Q.191 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Q.191 Hydrogen bonds: A:H.80, A:H.82 NAG.2: 5 residues within 4Å: Chain A: R.63, R.66, S.88, N.89, R.119 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.63, A:R.66, A:R.66, A:N.89 NAG.3: 1 residues within 4Å: Chain A: N.28 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.28 NAG.4: 4 residues within 4Å: Chain A: P.79, H.80, H.82, N.112 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:H.80

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hong, M. et al., A Novel Therapeutic Anti-ErbB3, ISU104 Exhibits Potent Antitumorigenic Activity by Inhibiting Ligand Binding and ErbB3 Heterodimerization. Mol.Cancer Ther. (2021)

Release Date

2021-04-07

Peptides

Receptor tyrosine-protein kinase erbB-3: A
Anti-ErbB3 Fab heavy chain: B
Anti-ErbB3 Fab light chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Receptor tyrosine-protein kinase erbB-3

Anti-ErbB3 Fab heavy chain

Anti-ErbB3 Fab light chain

Related Entries With Identical Sequence